HLB Pharmaceutical Co (XKRX:047920) Net Issuance of Debt : ₩10,903 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. HLB Pharmaceutical Co's net issuance of debt for the three months ended in Sep. 2024 was ₩0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2024 was ₩10,903 Mil.

HLB Pharmaceutical Co Net Issuance of Debt Historical Data

The historical data trend for HLB Pharmaceutical Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Net Issuance of Debt Chart

HLB Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

5,680.06

38,983.63

10,356.37

20,000.00

4,400.00

HLB Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Debt	Get a 7-Day Free Trial															-	-	10,903.09	-	-

HLB Pharmaceutical Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩10,903 Mil.

HLB Pharmaceutical Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

N/A

Address

67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR

Website

http://www.hlbpharma.co.kr

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines